Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsuedu.ru/handle/123456789/67124
Title: The impact of fixed-dose anatihypertensive therapy on cardiorenal syndrome markers in patients with acute coronary syndrome and comorbidities
Authors: Pribylov, S. A.
Leonidova, K. O.
Pribylov, V. S.
Gavrilyuk, E. V.
Pribylova, N. N.
Keywords: medicine
pharmacology
cardiorenal syndrome
acute coronary syndrome
chronic kidney disease
cystatin C
microalbuminuria
arterial stiffness
amlodipine
perindopril
treatment algorithm
Issue Date: 2026
Citation: The impact of fixed-dose anatihypertensive therapy on cardiorenal syndrome markers in patients with acute coronary syndrome and comorbidities / S.A. Pribylov, K.O. Leonidova, V.S. Pribylov [et al.] // Research Results in Pharmacology. - 2026. - Vol.12, №2.-P. 86-94. - DOI: 10.18413/rrpharmacology.12.1055. - Refer.: p. 94.
Abstract: Aim: To assess CRS marker dynamics and arterial stiffness in patients with ACS, AH, and chronic kidney disease (CKD) on standardized therapy, and to develop a treatment selection algorithm
URI: http://dspace.bsuedu.ru/handle/123456789/67124
Appears in Collections:Vol. 12, № 2

Files in This Item:
File Description SizeFormat 
Pribylov_The impact_26.pdf690.14 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.